Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Mounjaro vs Zepbound

Editorial comparison of Mounjaro (tirzepatide) and Zepbound (tirzepatide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionMounjaroZepbound
Generic nametirzepatidetirzepatide
ManufacturerEli LillyEli Lilly
FDA approved20222023
MechanismSame as Zepbound — dual GLP-1/GIP receptor agonist. Strong glycemic effect plus weight loss.Tirzepatide is a dual incretin agonist: it hits both the GLP-1 receptor (like semaglutide) and the GIP receptor (which semaglutide doesn't).
DosingTitrated 2.5mg → 15mg weekly over months, same schedule as Zepbound.Titrated 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg, every 4 weeks. Maintenance 5-15mg weekly depending on tolerability and target weight.
CostSimilar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month.List price ~$1,000-1,300/month.
Pivotal trial result2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose)20.9% mean body-weight reduction at 72 weeks (15 mg dose)

Full Mounjaro review →

FDA-approved tirzepatide for type 2 diabetes. Off-label for weight loss is common.

Full Zepbound review →

Dual GLP-1/GIP agonist for weight management. ~20% body weight loss in trials — strongest weight-loss drug currently available.

Frequently asked

Is Mounjaro or Zepbound more effective?+

In their pivotal trials, Mounjaro reported 2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose), while Zepbound reported 20.9% mean body-weight reduction at 72 weeks (15 mg dose). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Mounjaro and Zepbound compare on cost?+

Mounjaro: Similar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month. Zepbound: List price ~$1,000-1,300/month. Lilly's patient assistance program (LillyDirect Self-Pay) offers $399-549/month for self-pay patients depending on dose. Insurance coverage similar pattern to Wegovy. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Mounjaro to Zepbound?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Mounjaro and Zepbound the same drug?+

No. Mounjaro (tirzepatide) and Zepbound (tirzepatide) are distinct medications from Eli Lilly and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.